help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 63, No. 2 389-393
doi:10.1210/jcem-63-2-389
Copyright © 1986 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PIETSCHMANN, P.
Right arrow Articles by LUGER, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PIETSCHMANN, P.
Right arrow Articles by LUGER, A.

Effect of Cholinergic Muscarinic Receptor Blockade on Human Growth Hormone(GH)-Releasing Hormone-(l-44)-Induced GH Secretion in Acromegaly and Type I Diabetes Mellitus

P. PIETSCHMANN, G. SCHERNTHANER and A. LUGER

Department of Medicine II, Division of Metabolism and Endocrinology, University of Vienna Vienna, Austria

Address all correspondence and requests for reprints to: Univ. Doz. Dr. G. Schernthaner, Department of Medicine II, Division of Metabolism and Endocrinology, University of Vienna, Garnisongasse 13, A-1090 Vienna, Austria.

In 10 patients with type I diabetes mellitus, 9 acromegalic patients, and 8 normal subjects, serum GH levels after an iv injection of 1 µg/kg BW human GH-releasing hormone-(l-44) (GHRH) with and without cholinergic muscarinic receptor blockade (1 mg atropine, im, 15 min before GHRH) were measured. The GH increase after GHRH treatment in type I diabetic patients did not differ significantly from that in normal subjects. Pretreatment with atropine almost completely blocked the GH response to GHRH in patients with type I diabetes and normal subjects, but did not suppress the GH response to GHRH in acromegalic patients. These data indicate that cholinergic muscarinic receptors modulate GH secretion in normal man as well as in patients with type I diabetes mellitus, whereas acromegalic patients have a defect of cholinergic control of GH secretion.

Received December 12, 1985.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
C. Maier, G. Schaller, B. Buranyi, P. Nowotny, G. Geyer, M. Wolzt, and A. Luger
The Cholinergic System Controls Ghrelin Release and Ghrelin-Induced Growth Hormone Release in Humans
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4729 - 4733.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society